Ligand validation:6X2E

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 6X2E designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6X2E_NAD_C_400	93%	39%	0.075	0.968	1.57	0.85	7	3	1	0	100%	1
6X2E_NAD_A_400	62%	42%	0.134	0.926	1.43	0.85	7	2	2	0	100%	1
6X2E_NAD_D_400	30%	56%	0.185	0.847	0.89	0.82	1	2	2	0	100%	0.67
6WYC_NAD_B_400	98%	63%	0.058	0.981	0.61	0.81	-	1	0	0	100%	1
6OK4_NAD_A_401	76%	69%	0.123	0.96	0.55	0.64	-	1	0	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
2BJK_NAD_A_1517	100%	59%	0.025	0.995	0.72	0.86	-	1	1	0	100%	0.86
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.